CD86 and neoplasm: Using subcutaneous tumor tissues in Fig. 1O, tumor-infiltrating CD86+ M1 macrophages was significantly higher in PRMT1 knockdown groups than control ones, as tumor-infiltrating CD206+ M2 macrophages significantly lower (Fig. 3M–O).